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SHORT COMMUNICATION
In vivo toxicity study of phage lysate in chickens
A. OLIVEIRA1, R. SERENO, A. NICOLAU1 AND J. AZEREDO1
Research and Development Department, Controlvet, Seguranc¸a Alimentar, S.A., Tondela, Portugal and
1IBB, Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, Universidade do Minho,
Braga, Portugal
Abstract 1. Bacteriophage (phage) crude lysate of Gram-negative bacteria often contains bacterial
debris, including lipopolysaccharides found in the outer membrane of the cell wall, which are
potentially toxic.
2. In this study, an in vivo evaluation of the toxicity of a suspension of three phages to control
pathogenic Escherichia coli strains in poultry was performed.
3. Eighteen commercial layers, 7 weeks old, were intramuscularly injected with phage lysate
(8.21 104 Endotoxin Units/dose). The control group was injected with sterile Luria Bertani (LB)
broth.
4. Bird prostration and decrease in body weight gain and water intake per gram of body weight were
observed only on the day of the inoculation in the challenged group. Over the following 6 d, no
differences were observed in the chickens’ activity.
5. These results support the view that phage crude lysate carrying endotoxins are not toxic for
chickens.
INTRODUCTION
Lytic bacteriophages (phages) are viruses that
infect and promote bacterial lysis through a
multiple-step process: they multiply in the host
bacteria and lyse it at the end of the cycle, after
immediate replication of new phage particles.
They are regarded as good candidates for
antimicrobial therapy, as they provide an opp-
ortunity to control bacterial infections.
Bacteriophages are safe once they exclusively
infect bacterial cells, having no activity against
animal or plant cells. Like all viruses, phages are
metabolically inert in extracellular form and they
are ubiquitous in nature (Huff et al., 2005).
Nevertheless, as phage infections culminate in
lysis of bacteria, there is a consequent release of
cell wall components to the environment as cell
debris. In this process, Gram-negative bacteria
release endotoxin, whose biological activity is
associated with complexes of lipopolysaccharides
(LPS), present in the outer layer membrane. This
can lead to undesired side effects with phage
therapy. The LPS toxicity is associated with the
lipidic component of the molecule, known as
‘‘Lipid A’’, while the immunogenicity is asso-
ciated with the polysaccharide component,
known as ‘‘O-specific side chain’’ or ‘‘O-antigen’’
(Culbertson and Osburn, 1980; Prins et al., 1994;
Williams, 2001b; Todar, 2002; Boratyn´ski et al.,
2004). Thus, LPS are present in the cellular
debris in crude phage lysates, easily passing
through filters used to remove whole bacteria
from phage suspensions (Williams, 2001b).
The endotoxins induce a variety of inflam-
matory responses, being often part of the
pathology of Gram-negative bacterial infections.
Although animals vary in their susceptibility to
endotoxins, the sequence of pathophysiological
reactions follows a general pattern: a latent
period followed by physiological distress.
Immunologic and neurological system activation,
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induction of blood coagulation, general meta-
bolic effects, alteration of blood cell populations,
pyrogenicity, production of endotoxic shock and
hepatotoxicity are some of the known reactions
to an endotoxin parenteral challenge, promoting
symptoms like fever, diarrhoea, prostration and,
in many cases, shock and death (Culbertson
and Osburn, 1980; Williams, 2001a). Removal of
endotoxins from solutions intended to be used
in humans or animals is therefore an important
area for study, but the success of this procedure
is dependent on the initial composition of the
mixture (Petsch and Anspach, 2000; Boratyn´ski
et al., 2004). Ultrafiltration and size-exclusion
chromatography should theoretically provide
a way of separating components differing in
molecular mass. However, the application of
these two down stream processes in the purifica-
tion of phages removes only some of the
contaminants present in the phage suspension.
Despite their relatively low molecular weight
(4—20 kDa for LPS monomer), endotoxins are
not effectively removed as they tend to aggregate
forming structures similar to micelles and vesi-
cles, ranging in molecular weight from 300 000 to
1 million, with diameters up to 01mm (Williams,
2001b; Boratyn´ski et al., 2004). Other approaches
to achieving destruction or removal of endotox-
ins, like hydrolysis with acid or base, oxidation,
alkylation, heat treatment and treatment with
polymicin B have been reported (Davies, 1999).
However, the economical viability of scaling up
the process and the possibility of compromising
the recovery rate of the phages needs evaluation.
Petsch and Anspach (2000) report that the
question of economical endotoxin removal has
occupied many investigators and has been the
reason for process rearrangements.
Our in vivo trial with an E. coli phage crude
lysate, administered intramuscularly to chickens,
was conducted in order to evaluate the endo-
toxin effect and to assess the importance of
endotoxin removal in ensuring the safety of this
phage product for the target species.
MATERIALS AND METHODS
E. coli phage lysate
Crude phage suspensions were prepared by
inoculating a single phage plaque of the phages
phi F78E, phi F258E and phi F61E in 10 ml of
the respective E. coli host H561E, H816E and
H161E, mid-log grown (3—4 h) into Luria Bertani
(LB) broth (Sigma) (Oliveira et al., 2009). This
was followed by overnight incubation at 37C
with shaking (120 rpm). The suspension was
centrifuged (9000 g) for 10 min (rotor 19 776,
Sigma 3-16k), filtered through a 022-mm mem-
brane (Millipore) and, following the same
procedure as previously, inoculated again in
100 ml of mid-log grown culture of the respective
E. coli host. Incubation was performed at 37C
with shaking (120 rpm), centrifugation was at
9000 g for 10 min and filtration was through
022 mm. The phage crude lysate was stored at
4C. The number of phages in this suspension
was determined as described by Adams (1959)
with minor modifications. Successive dilutions of
the phage suspension were performed in phage
buffer (100 mmol/l NaCl (Sigma), 8 mmol/l
MgSO4 (Sigma), 50 mmol/l Tris (Sigma),
pH 75) and 100 ml of each dilution together
with 100 ml of the respective bacteria host
suspension were mixed with 3 ml of LB 06%
top agar layer and placed over a 15% LB agar
bottom layer. Plates were incubated at 37C for
12 h and phages enumerated in the higher
dilution with distinct plaques. Phage titration
was performed in triplicate.
Measurement of endotoxin concentration
The concentration of LPS present in the E. coli
phage lysate was measured using the Limulus
Amebocyte Lysate assay (LAL) (Bio-Whittaker),
which is based on the activation of Limulus
Lysate by endotoxins (Prins et al., 1994). The
procedure was as instructed by the supplier,
using a spectrophotometer (Bio-TEK Synergy
HT). This method was approved by FDA for
detection and quantification of endotoxins
(FDA, 1985).
Experimental design
This study was conducted according to the
Federation of European Laboratory Animal
Science Associations (FELASA) principles of
animal welfare, and the experiment was designed
in accordance to the European Council Directive
of 24 November 1986 (86/609/EEC) guidelines,
on the approximation of laws, regulations and
administrative provisions of the member States
regarding the protection of animals used for
experimental and other scientific purposes.
Thirty-six healthy 7-week-old growers (Rhode
Island Red) were used. Two groups of 18
chickens were selected at random and housed,
three per cage, in a temperature and relative
humidity controlled animal room, with a
12 h L:12 h D cycle. Birds were individually
identified by leg rings. Feed and water were
provided ad libitum. A volume of 1 ml of the
previously prepared phage suspension and 1 ml
of sterile LB broth were injected intramuscularly,
respectively in the challenged group (CHG) and
in the control group (CG), only on the first day.
The chickens’ body weight (BW) was recorded
the day before and every day after challenge.
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In order to avoid unnecessary discomfort to the
animals, the evaluation of chickens’ reaction to
challenge was based on behavioural observations.
Healthy chickens were recognised by their stand-
ing position, with neck strong and straight, flat
feathers against the body and high frequency of
seeking food and water. In contrast, if chickens
were sitting, lying still, with the neck weak and
drawn in, raised feathers, and not seeking food
or water, they were reported as prostrate.
Food and water consumption were recorded
daily. On day 7, all chickens were humanely killed
by isofluorane (IsoFlo, Abbott) inhalation and
submitted to post mortem examination.
Statistical analysis
Statistical analysis was undertaken for all depen-
dent variables: BW gain, feed and water intake
per gram of BW. CHG means were compared
with CG means at each data collecting period.
Statistical variance analysis was performed using
Kruskal—Wallis test in SPSS v1500 software.
Statistical significance was defined as P¼ 005.
RESULTS
E. coli phage lysate
The E. coli phage lysate is a mixture of
three phages phi F78E, phi F258E and phi
F61E, with the concentration of each phage
being 167 108 pfu/ml, 25 108 pfu/ml and
30 108 pfu/ml, respectively. The LAL test
revealed that the LPS concentration present in
this suspension was 821 104 Endotoxin Units
(EU)/ml.
In vivo challenge with phage lysate
A volume of 1 ml of phage lysate was adminis-
tered intramuscularly to the chickens of the
CHG, with the total amount of LPS being, on
average, 232 105 EU/kg BW.
During the in vivo experiment, bird prostra-
tion was observed only on the day of the
inoculation (day 1) in CHG. One bird died one
hour after inoculation but post mortem analysis
detected no macroscopic lesions in the internal
organs. During the following 6 d there were no
visual differences in activity between the two
groups. Regarding BW gain (Figure 1), on day 1
and day 6, this variable decreased in CHG birds
(P¼ 0043 and P¼ 0010, respectively). Feed and
water intake per gram of BW did not diverge
significantly between groups (Figures 2 and 3).
Water intake per gram of BW at day 1 decreased
in CHG birds, but with no relevant differences
between groups (P¼ 0065). On day 4, there was
a decrease (P¼ 0035) in CHG, however this
tendency was no longer observed in the
following days.
DISCUSSION
Phage therapy has been considered an important
alternative to the administration of antibiotics
in the treatment of severe E. coli infections in
birds (Huff et al., 2004, 2005). One concern
is the presence of endotoxins in the phage
crude lysate (Projan, 2004). In the present
work, 821 104 EU/ml LPS were found in the
prepared phage cocktail used. Nevertheless, the
chickens were challenged with 1ml of this
phage lysate containing approximately 232
105 EU/kg BW, which was not supposed to be
lethal, since, and according to Culbertson and
Figure 1. Chickens’ daily BW gain. In the figures, the solid line represents CG variation in body weight gain and the dashed line
represents the CHG variation. Error bars represent standard deviations of experimental data from the 6 cages of three animals each.
*Statistically different from CG.
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Osburn (1980), the lethal dose of Escherichia coli
endotoxins to chickens is 50 mg/kg or 5
108 EU/kg (1 EU/ml 10 ng/ml). Kokosharov
(2002) reported that little is known about LPS
activity in chickens and sometimes experimental
data are conflicting and divergent. The phage
lysate we administered has 10 times the volume,
and therefore might have about 10 times the LPS
content of the phage cocktails used for thera-
peutic purposes by Huff et al. (2004, 2005). These
authors did not observe any harmful effects on
chickens’ health and advise phage concentration
in therapeutic mixtures ranging between 107 and
109 pfu/ml (Huff et al., 2004, 2005).
During the in vivo trial, the birds challenged
with the phage lysate, as compared to the CG,
exhibited prostration and decreased feed and
water intake only during the day of inoculation:
subsequently, chickens’ behaviour did not show
visual differences between groups. Similar find-
ings were reported by Smith et al. (1978) during
an experiment with endotoxins from Salmonella
enterica serovar Gallinarum administered to 14-d-
old chicks. Despite the observation of some
clinical illness without mortality a few hours
after intravenous injection of 15 107 ng/kg
LPS, most of the responses returned to normal
within 24—48 h. Also Kokosharov (2002) observed
illness in cockerels one hour after injection of
50107 ng/kg LPS. Birds were described as
standing in the corners of the cages with signs
of depression, reluctance to move, somnolence,
Figure 3. Chickens’ water consumption per gram of BW. In the figures, the solid line represents CG variation in body weight gain
and the dashed line represents CHG variation. Error bars represent standard deviations of experimental data from the 6 cages of three
animals each. *Statistically different from CG.
Figure 2. Chickens’ feed consumption per gram of BW. In the figures, the solid line represents CG variation in body weight gain and
the dashed line represents the CHG variation. Error bars represent standard deviations of experimental data from the 6 cages of three
animals each.
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loss of thirst and appetite, and diarrhea, which all
gradually disappeared. This author did not
report any death among the cockerels
challenged.
In the present work, one chicken died one
hour after the intramuscular inoculation, prob-
ably due to anaphylactic shock, as no visible
lesions were found at necropsy. The statistically
significant decrease of BW gain in CHG at day 1
was probably due to the chickens’ prostration
and apparent loss of appetite. On day 6, the
differences between groups may be explained by
the occurrence of an unexpected factor during
the experiment: some feeders of the CG were
found empty in the morning, for the first time
since the beginning of the housing. As feed had
to be provided ad libitum, feeders were immedi-
ately refilled. This happened a few hours before
birds weighing and thus might had contributed
to the higher average weight in the CG.
Regarding water intake, the non-significant
decrease on day 1 in CHG was probably due to
the birds’ prostration. There is no explanation
for the significant decrease in water intake on
day 4. However, because water intake was there-
after similar in the two treatments, this difference
was probably not meaningful.
The absence of macroscopic lesions in the
internal organs of the euthanised birds suggested
that the phage lysate did not cause any visible
internal injurious effect.
For pharmaceutical purposes there are many
studies evaluating endotoxic effects in humans
and other animals, like toxicity evaluation of
antibiotic-induced endotoxin release, water pur-
ification for dialysis, and so on (Mathison &
Ulevitch, 1979; Shenep et al., 1985; Røkke et al.,
1988; Natanson et al., 1990; Friedland et al., 1993;
Martich et al., 1993; Nakamura et al., 1998;
Bru¨ssow, 2005). However, the variation in sensi-
tivity to endotoxin among species and the higher
resistance of chickens to endotoxin effects as
compared to mammals (Butler et al., 1977; Smith
et al., 1978; Culbertson & Osburn, 1980; Jones
et al., 1981), means that results from trials
with other animals are of limited relevance to
our findings.
In conclusion, apart from the immediate
short term reduction in activity, no adverse
effects were found in chickens challenged by
phage crude lysate containing 821 104 EU/ml
endotoxins, suggesting that phage crude lysate is
not toxic for chickens.
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